This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
Cyclin-dependent kinase
From Proteopedia
| Line 5: | Line 5: | ||
to a Jmol applet. Check out the other buttons as well! | to a Jmol applet. Check out the other buttons as well! | ||
--> | --> | ||
| - | '''Cyclin-dependent kinase''' (CDK) are serine/threonine kinases which are important to the regulation of the cell cycle. CDKs are small proteins which contain just a kinase domain. In order to function, CDK binds the regulatory protein cyclin. CDKs phosphorylate their substrates at a consensus tetrapeptide. The CDK classes differ by the binding cyclin and their function in human. | + | '''Cyclin-dependent kinase''' (CDK) are serine/threonine kinases which are important to the regulation of the cell cycle. CDKs are small proteins which contain just a kinase domain. In order to function, CDK binds the regulatory protein cyclin. CDKs phosphorylate their substrates at a consensus tetrapeptide. The CDK classes differ by the binding cyclin and their function in human.<br /> |
| + | |||
| + | • For details on '''CDK2''' see [[Cell Division Protein Kinase 2]]. <br /> | ||
| + | • '''CDK3''' binds cyclin C and functions during the G1 phase. <br /> | ||
| + | • For details on '''CDK4''' see [[Cyclin Dependent Kinase-4]]. <br /> | ||
| + | * '''CDK5''' binds p53 and functions during transcription. <br /> | ||
| + | • '''CDK6''' binds cyclin D and functions during the G1 phase. <br /> | ||
| + | • '''CDK7''' may serve as a direct link between transcription regulation and the cell cycle.<br /> | ||
| + | • '''CDK8''' binds cyclin C and functions during transcription. | ||
| + | • '''CDK12''' phosphorylates the C-terminal domain of the large subunit of RNA polymerase II. Acts as a regulator of transcription elongation. | ||
| + | • '''CDK16''' plays a role in vescicle-mdiated transport processes and exocytosis. | ||
==3D structures of cyclin-dependent kinase== | ==3D structures of cyclin-dependent kinase== | ||
| Line 11: | Line 21: | ||
Updated on {{REVISIONDAY2}}-{{MONTHNAME|{{REVISIONMONTH}}}}-{{REVISIONYEAR}} | Updated on {{REVISIONDAY2}}-{{MONTHNAME|{{REVISIONMONTH}}}}-{{REVISIONYEAR}} | ||
| - | ===CDK2 | + | ===CDK2=== |
| + | See [[Cell Division Protein Kinase 2]] | ||
===CDK3=== | ===CDK3=== | ||
| Line 18: | Line 29: | ||
[[1fpz]] – hCDK3 (mutant) | [[1fpz]] – hCDK3 (mutant) | ||
| - | ===CDK4 | + | ===CDK4=== |
===CDK5=== | ===CDK5=== | ||
Revision as of 09:01, 12 August 2014
Template:STRUCTURE 3rgf
Cyclin-dependent kinase (CDK) are serine/threonine kinases which are important to the regulation of the cell cycle. CDKs are small proteins which contain just a kinase domain. In order to function, CDK binds the regulatory protein cyclin. CDKs phosphorylate their substrates at a consensus tetrapeptide. The CDK classes differ by the binding cyclin and their function in human.
• For details on CDK2 see Cell Division Protein Kinase 2.
• CDK3 binds cyclin C and functions during the G1 phase.
• For details on CDK4 see Cyclin Dependent Kinase-4.
- CDK5 binds p53 and functions during transcription.
• CDK6 binds cyclin D and functions during the G1 phase.
• CDK7 may serve as a direct link between transcription regulation and the cell cycle.
• CDK8 binds cyclin C and functions during transcription.
• CDK12 phosphorylates the C-terminal domain of the large subunit of RNA polymerase II. Acts as a regulator of transcription elongation.
• CDK16 plays a role in vescicle-mdiated transport processes and exocytosis.
Contents |
3D structures of cyclin-dependent kinase
Updated on 12-August-2014
CDK2
See Cell Division Protein Kinase 2
CDK3
1fpz – hCDK3 (mutant)
CDK4
CDK5
1h4l – hCDK5 + CDK5 activator
1ung, 1unh, 1unl - hCDK5 (mutant) + CDK5 activator + inhibitor
3o0g - hCDK5 + ATP analog + CDK5 activator
CDK6
1bi7 – hCDK6 + multiple tumor suppressor
1bi8, 1blx – hCDK6 + CDK protein inhibitor
1g3n – hCDK6 + cyclin D homolog + CDK protein inhibitor
1jow – hCDK6 + V-cyclin
3nup, 3nux, 4aua, 4ez5 – hCDK6 + inhibitor
1xo2, 2f2c, 2euf, 4tth – hCDK6 + V-cyclin + inhibitor
CDK7
1ua2 – hCDK7
CDK8
4g6l – hCDK8 + cyclin C
3rgf, 4f6s, 4f6u, 4f6w, 4f70, 4f7j, 4f7l, 4f7n – hCDK8 + cyclin C + inhibitor
4f7s – hCDK8 + cyclin C + phenylethyl-quinazolin-amine
CDK9
3blh, 4ec8, 4ec9 – hCDK9-P + cyclin T1 (mutant)
3blq – hCDK9-P + cyclin T1 (mutant) + ATP
3lq5, 3my1, 3tn8, 3tnh, 3tni, 4bcf, 4bcg, 4bch, 4bci, 4bcj – hCDK9-P + cyclin T1 (mutant) + inhibitor
3blr – hCDK9-P + cyclin T1 + flavopiridol
3mi9, 3mia – hCDK9-P + cyclin T1 + HIV-1 TAT
4or5, 4ogr – hCDK9-P + cyclin T1 + HIV-1 TAT + major CDK9 elongation factor-associated protein
4imy – hCDK9-P + cyclin T1 + CDK9 elongation factor-associated protein
CDK12
4cjy, 4un0 – hCDK12-P + cyclin K
4nst – hCDK12-P + cyclin K + AlF3
4cxa – hCDK12-P + cyclin K + AMPPNP
CDK16
3mtl – hCDK16 (mutant) + indirubin
